Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Retinal Biologics Market Growth (Status and Outlook) 2022-2028

  • LP 4917275
  • 88 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Retinal Biologics will have significant change from previous year. According to our (LP Information) latest study, the global Retinal Biologics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Retinal Biologics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Retinal Biologics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Retinal Biologics market, reaching US$ million by the year 2028. As for the Europe Retinal Biologics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Retinal Biologics players cover Spark Therapeutics, Inc, F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals, Inc, and AbbVie Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Retinal Biologics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Macular Degeneration

Diabetic Retinopathy

Diabetic Macular Edema

Uveitis

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Clinics

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Spark Therapeutics, Inc

F. Hoffmann-La Roche Ltd

Regeneron Pharmaceuticals, Inc

AbbVie Inc

Johnson & Johnson Services, Inc

Amgen Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Retinal Biologics Market Size 2017-2028

2.1.2 Retinal Biologics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Retinal Biologics Segment by Type

2.2.1 Macular Degeneration

2.2.2 Diabetic Retinopathy

2.2.3 Diabetic Macular Edema

2.2.4 Uveitis

2.2.5 Others

2.3 Retinal Biologics Market Size by Type

2.3.1 Retinal Biologics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Retinal Biologics Market Size Market Share by Type (2017-2022)

2.4 Retinal Biologics Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Retinal Biologics Market Size by Application

2.5.1 Retinal Biologics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Retinal Biologics Market Size Market Share by Application (2017-2022)

3 Retinal Biologics Market Size by Player

3.1 Retinal Biologics Market Size Market Share by Players

3.1.1 Global Retinal Biologics Revenue by Players (2020-2022)

3.1.2 Global Retinal Biologics Revenue Market Share by Players (2020-2022)

3.2 Global Retinal Biologics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Retinal Biologics by Regions

4.1 Retinal Biologics Market Size by Regions (2017-2022)

4.2 Americas Retinal Biologics Market Size Growth (2017-2022)

4.3 APAC Retinal Biologics Market Size Growth (2017-2022)

4.4 Europe Retinal Biologics Market Size Growth (2017-2022)

4.5 Middle East & Africa Retinal Biologics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Retinal Biologics Market Size by Country (2017-2022)

5.2 Americas Retinal Biologics Market Size by Type (2017-2022)

5.3 Americas Retinal Biologics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Retinal Biologics Market Size by Region (2017-2022)

6.2 APAC Retinal Biologics Market Size by Type (2017-2022)

6.3 APAC Retinal Biologics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Retinal Biologics by Country (2017-2022)

7.2 Europe Retinal Biologics Market Size by Type (2017-2022)

7.3 Europe Retinal Biologics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Retinal Biologics by Region (2017-2022)

8.2 Middle East & Africa Retinal Biologics Market Size by Type (2017-2022)

8.3 Middle East & Africa Retinal Biologics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Retinal Biologics Market Forecast

10.1 Global Retinal Biologics Forecast by Regions (2023-2028)

10.1.1 Global Retinal Biologics Forecast by Regions (2023-2028)

10.1.2 Americas Retinal Biologics Forecast

10.1.3 APAC Retinal Biologics Forecast

10.1.4 Europe Retinal Biologics Forecast

10.1.5 Middle East & Africa Retinal Biologics Forecast

10.2 Americas Retinal Biologics Forecast by Country (2023-2028)

10.2.1 United States Retinal Biologics Market Forecast

10.2.2 Canada Retinal Biologics Market Forecast

10.2.3 Mexico Retinal Biologics Market Forecast

10.2.4 Brazil Retinal Biologics Market Forecast

10.3 APAC Retinal Biologics Forecast by Region (2023-2028)

10.3.1 China Retinal Biologics Market Forecast

10.3.2 Japan Retinal Biologics Market Forecast

10.3.3 Korea Retinal Biologics Market Forecast

10.3.4 Southeast Asia Retinal Biologics Market Forecast

10.3.5 India Retinal Biologics Market Forecast

10.3.6 Australia Retinal Biologics Market Forecast

10.4 Europe Retinal Biologics Forecast by Country (2023-2028)

10.4.1 Germany Retinal Biologics Market Forecast

10.4.2 France Retinal Biologics Market Forecast

10.4.3 UK Retinal Biologics Market Forecast

10.4.4 Italy Retinal Biologics Market Forecast

10.4.5 Russia Retinal Biologics Market Forecast

10.5 Middle East & Africa Retinal Biologics Forecast by Region (2023-2028)

10.5.1 Egypt Retinal Biologics Market Forecast

10.5.2 South Africa Retinal Biologics Market Forecast

10.5.3 Israel Retinal Biologics Market Forecast

10.5.4 Turkey Retinal Biologics Market Forecast

10.5.5 GCC Countries Retinal Biologics Market Forecast

10.6 Global Retinal Biologics Forecast by Type (2023-2028)

10.7 Global Retinal Biologics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Spark Therapeutics, Inc

11.1.1 Spark Therapeutics, Inc Company Information

11.1.2 Spark Therapeutics, Inc Retinal Biologics Product Offered

11.1.3 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Spark Therapeutics, Inc Main Business Overview

11.1.5 Spark Therapeutics, Inc Latest Developments

11.2 F. Hoffmann-La Roche Ltd

11.2.1 F. Hoffmann-La Roche Ltd Company Information

11.2.2 F. Hoffmann-La Roche Ltd Retinal Biologics Product Offered

11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.2.5 F. Hoffmann-La Roche Ltd Latest Developments

11.3 Regeneron Pharmaceuticals, Inc

11.3.1 Regeneron Pharmaceuticals, Inc Company Information

11.3.2 Regeneron Pharmaceuticals, Inc Retinal Biologics Product Offered

11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Regeneron Pharmaceuticals, Inc Main Business Overview

11.3.5 Regeneron Pharmaceuticals, Inc Latest Developments

11.4 AbbVie Inc

11.4.1 AbbVie Inc Company Information

11.4.2 AbbVie Inc Retinal Biologics Product Offered

11.4.3 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AbbVie Inc Main Business Overview

11.4.5 AbbVie Inc Latest Developments

11.5 Johnson & Johnson Services, Inc

11.5.1 Johnson & Johnson Services, Inc Company Information

11.5.2 Johnson & Johnson Services, Inc Retinal Biologics Product Offered

11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Johnson & Johnson Services, Inc Main Business Overview

11.5.5 Johnson & Johnson Services, Inc Latest Developments

11.6 Amgen Inc

11.6.1 Amgen Inc Company Information

11.6.2 Amgen Inc Retinal Biologics Product Offered

11.6.3 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Amgen Inc Main Business Overview

11.6.5 Amgen Inc Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Retinal Biologics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Macular Degeneration

Table 3. Major Players of Diabetic Retinopathy

Table 4. Major Players of Diabetic Macular Edema

Table 5. Major Players of Uveitis

Table 6. Major Players of Others

Table 7. Retinal Biologics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Retinal Biologics Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Retinal Biologics Market Size Market Share by Type (2017-2022)

Table 10. Retinal Biologics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Retinal Biologics Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Retinal Biologics Market Size Market Share by Application (2017-2022)

Table 13. Global Retinal Biologics Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Retinal Biologics Revenue Market Share by Player (2020-2022)

Table 15. Retinal Biologics Key Players Head office and Products Offered

Table 16. Retinal Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Retinal Biologics Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Retinal Biologics Market Size Market Share by Regions (2017-2022)

Table 21. Americas Retinal Biologics Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Retinal Biologics Market Size Market Share by Country (2017-2022)

Table 23. Americas Retinal Biologics Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Retinal Biologics Market Size Market Share by Type (2017-2022)

Table 25. Americas Retinal Biologics Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Retinal Biologics Market Size Market Share by Application (2017-2022)

Table 27. APAC Retinal Biologics Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Retinal Biologics Market Size Market Share by Region (2017-2022)

Table 29. APAC Retinal Biologics Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Retinal Biologics Market Size Market Share by Type (2017-2022)

Table 31. APAC Retinal Biologics Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Retinal Biologics Market Size Market Share by Application (2017-2022)

Table 33. Europe Retinal Biologics Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Retinal Biologics Market Size Market Share by Country (2017-2022)

Table 35. Europe Retinal Biologics Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Retinal Biologics Market Size Market Share by Type (2017-2022)

Table 37. Europe Retinal Biologics Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Retinal Biologics Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Retinal Biologics Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Retinal Biologics Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Retinal Biologics Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Retinal Biologics Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Retinal Biologics Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Retinal Biologics Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Retinal Biologics

Table 46. Key Market Challenges & Risks of Retinal Biologics

Table 47. Key Industry Trends of Retinal Biologics

Table 48. Global Retinal Biologics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Retinal Biologics Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Retinal Biologics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Retinal Biologics Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Retinal Biologics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Retinal Biologics Market Size Market Share Forecast by Application (2023-2028)

Table 54. Spark Therapeutics, Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors

Table 55. Spark Therapeutics, Inc Retinal Biologics Product Offered

Table 56. Spark Therapeutics, Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Spark Therapeutics, Inc Main Business

Table 58. Spark Therapeutics, Inc Latest Developments

Table 59. F. Hoffmann-La Roche Ltd Details, Company Type, Retinal Biologics Area Served and Its Competitors

Table 60. F. Hoffmann-La Roche Ltd Retinal Biologics Product Offered

Table 61. F. Hoffmann-La Roche Ltd Main Business

Table 62. F. Hoffmann-La Roche Ltd Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. F. Hoffmann-La Roche Ltd Latest Developments

Table 64. Regeneron Pharmaceuticals, Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors

Table 65. Regeneron Pharmaceuticals, Inc Retinal Biologics Product Offered

Table 66. Regeneron Pharmaceuticals, Inc Main Business

Table 67. Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Regeneron Pharmaceuticals, Inc Latest Developments

Table 69. AbbVie Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors

Table 70. AbbVie Inc Retinal Biologics Product Offered

Table 71. AbbVie Inc Main Business

Table 72. AbbVie Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. AbbVie Inc Latest Developments

Table 74. Johnson & Johnson Services, Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors

Table 75. Johnson & Johnson Services, Inc Retinal Biologics Product Offered

Table 76. Johnson & Johnson Services, Inc Main Business

Table 77. Johnson & Johnson Services, Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Johnson & Johnson Services, Inc Latest Developments

Table 79. Amgen Inc Details, Company Type, Retinal Biologics Area Served and Its Competitors

Table 80. Amgen Inc Retinal Biologics Product Offered

Table 81. Amgen Inc Main Business

Table 82. Amgen Inc Retinal Biologics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Amgen Inc Latest Developments

List of Figures

Figure 1. Retinal Biologics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Retinal Biologics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Retinal Biologics Market Size Market Share by Type in 2021

Figure 7. Retinal Biologics in Hospitals

Figure 8. Global Retinal Biologics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Retinal Biologics in Clinics

Figure 10. Global Retinal Biologics Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Retinal Biologics in Others

Figure 12. Global Retinal Biologics Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Retinal Biologics Market Size Market Share by Application in 2021

Figure 14. Global Retinal Biologics Revenue Market Share by Player in 2021

Figure 15. Global Retinal Biologics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Retinal Biologics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Retinal Biologics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Retinal Biologics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Retinal Biologics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Retinal Biologics Value Market Share by Country in 2021

Figure 21. Americas Retinal Biologics Consumption Market Share by Type in 2021

Figure 22. Americas Retinal Biologics Market Size Market Share by Application in 2021

Figure 23. United States Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Retinal Biologics Market Size Market Share by Region in 2021

Figure 28. APAC Retinal Biologics Market Size Market Share by Application in 2021

Figure 29. China Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Retinal Biologics Market Size Market Share by Country in 2021

Figure 36. Europe Retinal Biologics Market Size Market Share by Type in 2021

Figure 37. Europe Retinal Biologics Market Size Market Share by Application in 2021

Figure 38. Germany Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Retinal Biologics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Retinal Biologics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Retinal Biologics Market Size Market Share by Application in 2021

Figure 46. Egypt Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Retinal Biologics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 55. United States Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 59. China Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 63. India Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 66. France Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 67. UK Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Retinal Biologics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Retinal Biologics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450